| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/10/1997 | WO1997012974A2 Kidney atp-dependent potassium channels |
| 04/10/1997 | WO1997012972A2 Regulated genes and uses thereof |
| 04/10/1997 | WO1997012970A1 Antitumour vector constructs and methods |
| 04/10/1997 | WO1997012968A1 Retroviral vectors pseudotyped with srv-3 envelope glycoprotein sequences |
| 04/10/1997 | WO1997012966A1 Colloidal silica films for cell culture |
| 04/10/1997 | WO1997012961A2 Growth of adult pancreatic islet cells with laminin 5 |
| 04/10/1997 | WO1997012960A2 Solid support for use in cell cultivation, especially for the cultivation of liver cells, biological reactor containing said solid support and the use thereof in a bio-artificial liver system |
| 04/10/1997 | WO1997012633A1 Dendritic cell stimulatory factor |
| 04/10/1997 | WO1997005250A3 Receptor ligand vegf-c |
| 04/10/1997 | WO1997000319A3 Chimeric leptin fused to immunoglobulin domain and use |
| 04/10/1997 | WO1996019099A3 Use of vitamin c or derivatives or analogues thereof for promoting skin elastin synthesis |
| 04/10/1997 | DE19608769C1 Monoclonal antibody BV10A4H2 specific for human FLT3/FLK2 receptor |
| 04/10/1997 | CA2234219A1 Retroviral vectors pseudotyped with srv-3 envelope glycoprotein sequences |
| 04/10/1997 | CA2234061A1 Multi-functional hematopoietic receptor agonists |
| 04/10/1997 | CA2234045A1 Interleuken-3 (il-3) receptor agonists |
| 04/10/1997 | CA2233859A1 Growth of adult pancreatic islet cells |
| 04/10/1997 | CA2233059A1 Biologically-active polymers |
| 04/10/1997 | CA2232865A1 The use of flt3 ligand to generate dendritic cells |
| 04/10/1997 | CA2230957A1 Regulated genes and uses thereof |
| 04/09/1997 | EP0767381A1 Detection, quantification and classification of ras proteins in body fluids and tissues |
| 04/09/1997 | EP0767178A1 Protein which induces interferon-gamma production by immunocompetent cell |
| 04/09/1997 | EP0766745A1 Monoclonal antibody specific for human 4-1bb and cell line producing same |
| 04/09/1997 | EP0766743A2 Transformation of guar |
| 04/09/1997 | EP0766733A1 A purified mixture of collagenases and two other proteases obtained from clostridium histolyticum |
| 04/09/1997 | EP0766698A1 Isolated nucleic acid encoding retinol dehydrogenase |
| 04/09/1997 | EP0766693A1 Novel parasite protease genes and proteins |
| 04/09/1997 | EP0766510A2 Use of a commiphora mukul extract as a pigmenting agent |
| 04/09/1997 | EP0666912B1 Modified ciliary neurotrophic factors |
| 04/09/1997 | EP0580760A4 Totipotent hematopoietic stem cell receptors and their ligands |
| 04/09/1997 | CN1147272A Spider neurotoxins and method of producing the same |
| 04/09/1997 | CN1147014A Phytocyte anti-senescence agent (PG) |
| 04/08/1997 | US5618720 Cells expressing calcium channel α2 subunit-encoding DNA, optionally with a reporter gene for screening assays |
| 04/08/1997 | US5618718 Production of a contractile smooth muscle |
| 04/08/1997 | US5618714 Methods for producing protein C |
| 04/08/1997 | US5618712 Purified, isolated recombinant dna molecule coding for human lysozyme |
| 04/08/1997 | US5618698 Growing host cells transformed or transfected with specified isolated dna sequence, isolating erythropoietin product |
| 04/08/1997 | US5618691 Recombinant DNA encoding a eukaryotic tyrosine kinase target protein |
| 04/08/1997 | US5618678 Methods for detecting PDGF agonist or antagonist activity using PDGF .alpha. |
| 04/08/1997 | US5618663 Device for producing a supernatant of activated thrombocytes, method for implementing the device and supernatant obtained |
| 04/08/1997 | US5618549 Bone diseases such as osteoporosis |
| 04/08/1997 | US5618536 Chimeric papillomavirus-like particles |
| 04/08/1997 | US5618534 Isolated antigen endo glyx-1 |
| 04/08/1997 | US5618532 Dirofilaria immitis Gp29 proteins and uses thereof |
| 04/08/1997 | US5618531 Method for increasing the viability of cells which are administered to the brain or spinal cord |
| 04/03/1997 | WO1997012060A1 ARF-p19, A NOVEL REGULATOR OF THE MAMMALIAN CELL CYCLE |
| 04/03/1997 | WO1997012049A1 Materials and methods relating to the transfer of nucleic acid into quiescent cells |
| 04/03/1997 | WO1997012047A1 Plant stearoyl-acp thioesterase sequences and methods to increase stearate content in plant seed oils |
| 04/03/1997 | WO1997012046A1 Improved integration of exogenous dna delivered to eukaryotic cells |
| 04/03/1997 | WO1997012041A1 SHORT FORMS OF CHEMOKINE β-8 |
| 04/03/1997 | WO1997012037A1 A novel haemopoietin receptor and genetic sequences encoding same |
| 04/03/1997 | WO1997012035A2 Transgenic animals for xenotransplantation with reduced antibody-mediated rejection |
| 04/03/1997 | WO1997012033A1 Recombinant hepatitis c virus rna replicase |
| 04/03/1997 | WO1997012032A1 Production of infectious respiratory syncytial virus from cloned nucleotide sequences |
| 04/03/1997 | WO1997011970A1 Cytostatin ii |
| 04/03/1997 | WO1997011965A1 Method for treating alzheimer's disease using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 04/03/1997 | WO1997011956A1 IDENTIFICATION OF sel-12 AND USES THEREOF |
| 04/03/1997 | WO1997011716A1 Manipulation of non-terminally differentiated cells using the notch pathway |
| 04/03/1997 | WO1997011685A1 Method for synthesizing microcapsules of predetermined permeability |
| 04/03/1997 | WO1997011607A1 Method of inhibiting immune system destruction of transplanted viable cells |
| 04/03/1997 | WO1997011604A1 Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains |
| 04/03/1997 | WO1997011597A1 Method for preparing transgenic animal |
| 04/03/1997 | WO1997003192A3 Chromosome 1 gene and gene products related to alzheimer's disease |
| 04/03/1997 | WO1996040948A3 Resistance to viruses and viroids in transgenic plant and animal hosts expressing dsrna-binding protein |
| 04/03/1997 | CA2233694A1 Method for preparing transgenic animal |
| 04/03/1997 | CA2233309A1 Recombinant hepatitis c virus rna replicase |
| 04/03/1997 | CA2233297A1 Identification of sel-12 and uses thereof |
| 04/03/1997 | CA2233040A1 Transgenic animals for xenotransplantation with reduced antibody-mediated rejection |
| 04/03/1997 | CA2232870A1 Method for synthesizing microcapsules of predetermined permeability |
| 04/03/1997 | CA2232815A1 Method of inhibiting immune system destruction of transplanted viable cells |
| 04/03/1997 | CA2231735A1 Materials and methods relating to the transfer of nucleic acid into quiescent cells |
| 04/03/1997 | CA2205657A1 Plant stearoyl-acp thioesterase sequences and methods to increase stearate content in plant seed oils |
| 04/02/1997 | EP0765884A1 Anti-inflammatory compound |
| 04/02/1997 | EP0765478A1 Positive and positive/negative cell selection mediated by peptide release |
| 04/02/1997 | EP0765398A1 Population of cells enriched for myeloid and/or lymphoid progenitors and methods of making and using |
| 04/02/1997 | EP0765393A1 Dna molecules which code for a plastid 2-oxoglutarate/malate translocator |
| 04/02/1997 | EP0765392A1 Interleukin-5 specific recombinant antibodies |
| 04/02/1997 | EP0765391A1 Cloning and expression of an acetylcholine-gated ion channel receptor subunit |
| 04/02/1997 | EP0765390A1 Alpha-lactalbumin gene constructs |
| 04/02/1997 | EP0765386A1 Methods for in vivo t cell activation by antigen-pulsed dendritic cells |
| 04/02/1997 | EP0765385A1 COMPOSITIONS AND METHOD OF STIMULATING THE PROLIFERATION AND DIFFERENTIATION OF HUMAN FETAL AND ADULT PANCREATIC CELLS $i(EX VIVO) |
| 04/02/1997 | EP0765343A1 MONOCLONAL ANTIBODY ACTIVE AGAINST CD44v6 |
| 04/02/1997 | EP0765342A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
| 04/02/1997 | EP0765172A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin |
| 04/02/1997 | EP0765168A1 Compositions and methods for the treatment of tumors |
| 04/02/1997 | EP0765159A1 Spin encapsulation apparatus and method of use |
| 04/02/1997 | EP0663951A4 Chitosan matrices for encapsulated cells. |
| 04/02/1997 | EP0660664A4 Preserved, non-infectious control cells for use in the identification of a disease through blood testing. |
| 04/02/1997 | EP0584170B1 Process and device for cultivating different mammal cells at the same time |
| 04/02/1997 | CN1146781A Riboflavin synthesis in fungi |
| 04/02/1997 | CN1146724A Heparin-binding protein for the treatment of sepsis and processes for its preparation |
| 04/02/1997 | CN1146712A Myoblast therapy for mammalian diseases |
| 04/02/1997 | CN1034427C Method of producing peptides, recombinant plasmid for use in same and animal cells transformed with same |
| 04/02/1997 | CN1034426C Cucumber mosaic virus coat protein gene |
| 04/01/1997 | US5616486 Tissue plasminogen activator having zymogenic or fibrin specific properties |
| 04/01/1997 | US5616483 Genomic DNA sequences encoding human BSSL/CEL |
| 04/01/1997 | US5616481 Genetic engineered dna technology in neurobiology |
| 04/01/1997 | US5616472 Process for producing monoclonal antibodies against human T cell receptor elements using recombinant DNA vectors, and cells transfected thereby |
| 04/01/1997 | US5616463 Stimulating cells with ionizing radiation, comparing level of gadd45 messenger rna in stimulated cells to that in unstimulated cells |
| 04/01/1997 | US5616323 Cucumis melo protein extract with antioxidant activity and process for preparing it, cosmetic or pharmaceutical composition or food composition containing such an extract |
| 04/01/1997 | CA1339032C Forms of colony stimulating factor-1 |